References
- Sander HM, Morris LF, Phillips CM et al, The annual cost of psoriasis [see comments]. J Am Acad Dermatol (1993) 28: 422–5.
- Ramsay B, O’Reagan M, A survey of the social and psychological effects of psoriasis. Br J Dermatol (1988) 118: 195–201.
- Koo J, Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin (1996) 14: 485–96.
- Devrimci-Ozguven H, Kundakci TN, Kumbasar H, Boyvat A, The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol (2000) 14: 267–71.
- Gupta MA, Gupta AK, Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol (1998) 139: 846–50.
- Fried RG, Friedman S, Paradis C et al, Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol (1995) 34: 101–5.
- Ginsburg IH, Link BG, Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol (1993) 32: 587–91.
- Feldman SR, Fleischer AB, Jr, Reboussin DM et al, The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol (1997) 37: 564–9.
- Rapp SR, Feldman SR, Exum ML et al, Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol (1999) 41: 401–7.
- Gupta MA, Gupta AK, Quality of life of psoriasis patients. J Eur Acad Dermatol Venereol (2000) 14: 241–2.
- Finlay AY, Khan GK, Luscombe DK, Salek MS, Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol (1990) 123: 751–6.
- Boumpas DT, Chrousos GP, Wilder RL et al, Glucocorti- coid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med (1993) 119: 1198–208.
- Kragballe K, Topical corticosteroids: mechanisms of action. Acta Derm Venereol Suppl (Stockh) (1989) 151: 7–10.
- Katz HI, Gross E, Buxman M et al, A double-blind, vehicle-controlled paired comparison of halobetasol propionate cream on patients with plaque psoriasis. J Am Acad Dermatol (1991) 25: 1175–8.
- Goldberg B, Hartdegen R, Presbury D et al, A double- blind, multicenter comparison of 0.05% halobetasol propionate ointment and 0.05% clobetasol propionate ointment in patients with chronic, localized plaque psoriasis. J Am Acad Dermatol (1991) 25: 1145–8.
- Krueger GG, O’Reilly MA, Weidner M et al, Comparative efficacy of once-daily flurandrenolide tape versus twice- daily diflorasone diacetate ointment in the treatment of psoriasis. J Am Acad Dermatol (1998) 38: 186–90.
- Blum G, Yawalkar S, A comparative, multicenter, double blind trial of 0.05% halobetasol propionate ointment and 0.1% betamethasone valerate ointment in the treatment of patients with chronic, localized plaque psoriasis. J Am Acad Dermatol (1991) 25: 1153–6.
- Shupack JL, Jondreau L, Kenny C, Stiller MJ, Diflorasone diacetate ointment 0.05% versus betamethasone dipro- pionate ointment 0.05% in moderate–severe plaque-type psoriasis. Dermatology (1993) 186: 129–32.
- Lebwohl M, Sherer D, Washenik K et al, A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. Int J Dermatol (2002) 41: 269–74.
- Feldman SR, Fleischer AB, Cooper JZ, New topical treatments change the pattern of treatment of psoriasis: dermatologists remain the primary providers of this care. Int J Dermatol (2000) 39: 41–4.
- Mason J, Mason AR, Cork MJ, Topical preparations for the treatment of psoriasis: a systematic review. Br J Dermatol (2002) 146: 351–64.
- Lee JY, Maibach HI, Corticosteroid skin atrophogenicity: assessment methods. Skin Res Technol (1998) 4: 161–6.
- Al Suwaidan SN, Feldman SR, Clearance is not a realistic expectation of psoriasis treatment. J Am Acad Dermatol (2000) 42: 796–802.
- Lebwohl M, Topical application of calcipotriene and corticosteroids: combination regimens. J Am Acad Dermatol (1997) 37: S55–8.
- Katz HI, Hien NT, Prawer SE et al, Superpotent topical steroid treatment of psoriasis vulgaris – clinical efficacy and adrenal function. J Am Acad Dermatol (1987) 16: 804–11.
- Garden JM, Freinkel RK, Systemic absorption of topical steroids. Metabolic effects as an index of mild hyper- cortisolism. Arch Dermatol (1986) 122: 1007–10.
- Fleischer AB, Jr, Feldman SR, Rapp SR et al, Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self- administered psoriasis area severity index scores. J Invest Dermatol (1996) 107: 26–9.